drugset

drugset / Trial / NCT00745368

Comparing Raltegravir Genital Tract Distribution in HIV-infected Men and Women

NCT00745368 ↗

Completed 28 enrolled University of Rochester Merck Sharp & Dohme LLC · collab

NaSingle-groupOpen-label

Summary

The purpose of this research study is to determine how much raltegravir gets into the male and female genital tract.

Timeline

Start: 2008-09
Primary completion: 2011-06
Completion: 2011-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Raltegravir	Other / unclassified	400 mg	—

Indications